The Strategic Way of API Industry Dominance NeedS to Change

         API of scare of economies in China has benefited from the production of low cost and environmental pollution,due to China's API quality for exports good and bad are intermingled,technical content is not high,frequently encountering anti-dumping,antitrust and other barriers to trade.In 2013,transformation and upgrading are the only way for the API industry.
         In the first three quarters of total exports for China's API,equivalent is to 76% of last year,which can predict that annual export growth will be below 5%.
         In 2012~2013 API exported into the second platform period,the international market demand for low-end based API space tends to saturation,high value API policy trend to improve the threshold.
         API industry struggling in the international market,mainly reflected in the excess production capacity,manufacturing costs rise faster,the RMB exchange rate constraints,and increasingly severe international regulation,etc.
         In the international market China's API's biggest rivals are India,although in the development of the industry scale is less than China,but on the cost advantage and industry development speed are better than China has obvious advantages.
         The global pharmaceutical industry transformation and upgrading trend became apparent,active pharmaceutical ingredients industry prospect,how to take advantage of active pharmaceutical ingredients into industry is concerned about hot spots.
         Being really cement industry dominance for API,which needs to speed up the pace of transformation and upgrading,to guarantee the quality of problems on the basis of active pharmaceutical ingredients to the preparation,characteristic transfer API production areas,change the development idea,from price advantage to technical superiority.
         To prevent counterfeit drugs into formal sales channels,to improve the import drug threshold in the European Union.Since July 2013,all Chinese exports to the EU's drugs all needs to issue a written statement exporter of regulators.The EU is API products in China's largest export market,the directive has caused concern in the industry.
         Chemical pharmaceuticals industry faces a serious problem in China,the degree of saturation,increased competition,innovation capacity is low,in this case,increasing international barriers to domestic enterprises caused great pressure.How to transfer pressure beckoning,out of a green road of the sustainable development become the most important question for API enterprises.
         API industry environment in 2014 is still not optimistic,competitive,environmental pressure are increasing,and the implementation of the new GMP standard,which is expected to be able to improve the industry concentration,for technology research and development ability,better products structure API enterprises will expand market share.

By Grant